Lack of the serotonin transporter (SERT) reduces the ability of 5-hydroxytryptamine to lower blood pressure

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 383, Issue 5, 2011, Pages 543-546

  Patrick Davis, Robert ^a   Linder, A Elizabeth ^b   Watts, Stephanie W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

5 HT; 5 Hydroxytryptamine; Blood pressure; Serotonin; Serotonin transporter (SERT)

Indexed keywords

SEROTONIN; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; FEMALE; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; SEROTONIN BLOOD LEVEL; SEX DIFFERENCE; TELEMETRY; WILD TYPE;

ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; DATA INTERPRETATION, STATISTICAL; FEMALE; HEART RATE; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, MUTANT STRAINS; RATS, WISTAR; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX CHARACTERISTICS;

EID: 79955693721     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-011-0622-1     Document Type: Article

References (13)

1. Brenner B, Harney JT, Ahmed BA, Jeffus BC, Unal R, Mehta JL, Kilic F (2007) Plasma serotonin levels and the platelet serotonin transporter. J Neurochem 102:206-215 (Pubitemid 46906271)
2. Chanrion B, Mannoury la Cour C, Bertaso F, Lerner-Natoli M, Freissmuth M, Millan MJ, Brockaert J, Martin P (2007) Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. PNAS 104:8119-8124 (Pubitemid 47185885)
3. Dahlstroem A, Fuxe K (1964) Evidence for the existence of monamine-containing neurons in the central nervous system. I. Demonstration of monamines in the cell bodies of brain stem neurons. Acta Physiol Scand 232(Suppl):1-55
4. Diaz J, Ni W, Thompson J, King A, Fink G, Watts SW (2008) 5-hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats. J Pharmacol Exp Ther 325:1031-1038 (Pubitemid 351724318)
5. Erspamer V, Aerso B (1952) Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature 169:800-801
6. Fetkovska N, Pletscher A, Ferracin F, Amstein R, Buhler FR (1990) Impaired uptake of 5-hydroxytryptamine in platelet in essential hypertension: clinical relevance. Cardiovasc Drugs Ther 4:105-109 (Pubitemid 20106962)
7. Homberg JR, Olivier JDA, Smits BMG, Mul JD, Mudde J, Verheul NOFM, Cools AR, Ronken E, Cremers T, Schoffelmeer ANM, Ellenbroek BA, Cuppen E (2007) Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system. Neuroscience 146:1662-1676 (Pubitemid 46783222)
8. Linder AE, Diaz J, Ni W, Szasz T, Burnett R, Watts SW (2008a) Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat. Am J Physiol Heart Circ Physiol 294:H1745-H1752 (Pubitemid 351490605)
9. Linder AE, Ni W, Szasz T, Burnett R, Diaz J, Geddes TJ, Kuhn DM, Watts SW (2008b) A serotonergic system in veins: serotonin transporter-independent uptake. J Pharmacol Exp Ther 325:714-722 (Pubitemid 351724308)
10. Maron E, Toru I, Hirvonen J et al. (2011) Gender differences in brain serotonin transporter availability in panic disorder. J Psychopharmacol (in press)
11. Nakatani Y, Sato-Suzuki I, Tsujino N, Nakasato A, Seki Y, Fumoto M (2008) Augmented brain 5-HT crosses the blood-brain barrier through the 5-HT transporter in rat. Eur J Neurosci 27:2466-2472 (Pubitemid 351590910)
12. Ni W, Thompson JM, Northcott CA, Lookingland K, Watts SW (2004) The serotonin transporter is present and functional in peripheral arterial smooth muscle. J Cardiovasc Pharmacol 43:770-781 (Pubitemid 38679598)
13. Rapport MM, Green AA, Page IH (1948) Serum vasoconstrictor (serotonin): IV isolation and characterization. J Biol Chem 176:1243-1251